Brought to you by 
Cytokinetics nets $95.9mm with IPO
Feb 2004
Executive Summary
Cell biology company Cytokinetics raised net proceeds of $95.9mm through its initial public offering. The company sold 7.9mm common shares (including the overallotment) at $13 a share. (It had originally hoped for 5.8mm shares at between $11-13 each.)
Deal Industry
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cytokinetics nets $95.9mm with IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice